Deep Brain Stimulation

Deep Brain Stimulation is a neurosurgical procedure that uses a neurostimulator to stimulate specific regions of the brain for treatment of movement disorders. Here is the latest research.

May 28, 2020
ReviewOpen Access

Sample Preparation Using Graphene-Oxide-Derived Nanomaterials for the Extraction of Metals

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Natalia ManousiGeorge A Zachariadis
May 30, 2020

Cardiac Autonomic Nerves Stimulation Improves Hemodynamics and Clinical Status in Advanced Heart Failure Patients

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
T DiazM Cuchiara
May 30, 2020

Treating Post-traumatic Stress Disorder with Neuromodulation Therapies: Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Flavia Venetucci GouveiaClement Hamani
May 27, 2020
Open Access

Direct Cost of Parkinson's Disease: A Real-World Data Study of Second-Line Therapies

Parkinson's Disease
Elisa Gomez-InhiestoElena Urizar
May 23, 2020

Deep-Hipo: Multi-scale Receptive Field Deep Learning for Histopathological Image Analysis

Methods : a Companion to Methods in Enzymology
Sai Chandra KosarajuMingon Kang
May 26, 2020

Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Parkinson's Disease?

Movement Disorders : Official Journal of the Movement Disorder Society
Margherita FabbriLeonardo Lopiano
May 27, 2020
Preprint

Targeted design of antiviral compounds against SARS-CoV-2 with conditional generative models

arXiv Quantitative Biology
Jannis BornMaría Rodríguez Martínez
May 30, 2020

Intrepidly studying deep brain stimulation in patients with Parkinson's disease

Lancet Neurology
Günther Deuschl, Paul Krack

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Alpha-Synuclein Structure and Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-Synuclein structure and function.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/deep-brain-stimulation/dc15fef4-7f02-4d18-88e7-53196dbbde73